Anti-SLC2A2 Antibody (8L284) is an antibody targeting SLC2A2. Anti-SLC2A2 Antibody (8L284) can be used in ELISA, IHC, IF, FC.

Rabbit IgG

8L284

Human

1. IHC image of TMAH-01103 diluted at 1:50 and staining in paraffin-embedded human liver cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.20% DAB.
2. Immunofluorescence staining of HepG2 with TMAH-01103 at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 495-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
3. Overlay Peak curve showing HepG2 cells surface stained with TMAH-01103 (red line) at 1:50. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1µg/1*10^6 cells) for 45min at 4°C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG(H+L) at 1:200 dilution for 35min at 4°C.Control antibody (green line) was rabbit IgG (1µg/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.

ELISA, IHC, IF, FC

IHC:1:50-1:200; IF:1:50-1:200; FC:1:50-1:200.

Monoclonal

Unconjugated

A synthetic peptide: Human SLC2A2

Human

6514

Cancer, Developmental biology, Metabolism, Signal transduction, Stem cells